K

KSQ Therapeutics, Inc.

101 employees

KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
CRISPR
Therapeutics
Immuno-Oncology
Functional Genomics
Pharmaceutical
Biopharma
Drug Discovery

Date founded

2015

Funding rounds raised

Total raised

$80M

from 9 investors over 9 rounds

K

KSQ Therapeutics, Inc. raised $80M on September 28, 2018

Investors: Lilly Asia Ventures, Polaris Partners, ARCH Venture Partners, Baillie Gifford, Flagship Ventures and The Invus Group

K

KSQ Therapeutics, Inc. raised $76M on October 2, 2017

Investors: Flagship Ventures, ARCH Venture Partners and Polaris Partners

FAQ